CEP131 Deficiency Leads to Multiple Morphological Abnormalities of the Sperm Flagellum-Associated Male Infertility

Xueling Chen1, Zhuyu Li2, Wensheng Liu3,4,5

  • 1Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.

Andrology
|June 16, 2026
PubMed
Abstract

Insights

CEP131 gene mutations cause multiple morphological abnormalities of the sperm flagellum (MMAF), leading to male infertility. Intracytoplasmic sperm injection (ICSI) showed poor outcomes due to embryonic arrest in MMAF patients with these mutations.

Area of Science:

  • Genetics
  • Reproductive Biology
  • Cell Biology

Background:

  • Multiple morphological abnormalities of the sperm flagellum (MMAF) is a severe subtype of asthenoteratozoospermia with largely unknown genetic causes.
  • Identifying the genetic basis of MMAF is crucial for understanding male infertility.

Purpose of the Study:

  • To discover novel genetic factors responsible for MMAF.
  • To assess the effectiveness of intracytoplasmic sperm injection (ICSI) for male infertility caused by MMAF.

Main Methods:

  • Whole-exome and Sanger sequencing were used to identify genetic variants in 124 infertile males with MMAF.
  • Sperm morphology, ultrastructure, and protein localization (CEP131, CEP290, PCM1) were analyzed.
  • Co-immunoprecipitation identified CEP131 interacting proteins; ICSI outcomes were evaluated.

Main Results:

  • Bi-allelic mutations in the CEP131 gene were identified in four MMAF patients, representing a novel genetic cause.
  • These CEP131 mutations led to centrosomal malformations and impaired sperm flagellar formation.
  • Two patients undergoing ICSI experienced embryonic development arrest, resulting in no transferable blastocysts.

Conclusions:

  • CEP131 mutations are a newly identified cause of MMAF and male infertility by disrupting sperm flagellar development through interaction with CEP290.
  • ICSI treatment for male infertility due to CEP131 mutations has a poor prognosis, with high rates of embryonic arrest.